U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C31H39ClN2O8
Molecular Weight 603.103
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAPAQUISTAT

SMILES

COC1=CC=CC([C@H]2O[C@H](CC(=O)N3CCC(CC(O)=O)CC3)C(=O)N(CC(C)(C)CO)C4=C2C=C(Cl)C=C4)=C1OC

InChI

InChIKey=HDGUKVZPMPJBFK-LEAFIULHSA-N
InChI=1S/C31H39ClN2O8/c1-31(2,18-35)17-34-23-9-8-20(32)15-22(23)28(21-6-5-7-24(40-3)29(21)41-4)42-25(30(34)39)16-26(36)33-12-10-19(11-13-33)14-27(37)38/h5-9,15,19,25,28,35H,10-14,16-18H2,1-4H3,(H,37,38)/t25-,28-/m1/s1

HIDE SMILES / InChI

Molecular Formula C31H39ClN2O8
Molecular Weight 603.103
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

LAPAQUISTAT is a squalene synthase inhibitor. It was shown to lower cholesterol levels in several animal models. It was investigated for the treatment of diabetes and hypercholesterolemia, however, its development was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia.
2011-05-10
Squalene synthase inhibition: a novel target for the management of dyslipidemia.
2007-01
Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
2003-07
Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
2002-09-26
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 19:40:50 GMT 2025
Edited
by admin
on Mon Mar 31 19:40:50 GMT 2025
Record UNII
PEZ79BV72X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LAPAQUISTAT
INN  
INN  
Official Name English
4-PIPERIDINEACETIC ACID, 1-(((3R,5S)-1-(3-(HYDROXY)-2,2-DIMETHYLPROPYL)-7-CHLORO-5-(2,3-DIMETHOXYPHENYL)-1,2,3,5-TETRAHYDRO-2-OXO-4,1-BENZOXAZEPIN-3-YL)ACETYL)-
Preferred Name English
T-91485
Code English
2-(1-(2-((3R,5S)-1-(3-HYDROXY-2,2-DIMETHYLPROPYL)-7-CHLORO-5-(2,3- DIMETHOXYPHENYL)-2-OXO-1,2,3,5-TETRAHYDROBENZO(E)(1,4)OXAZEPIN-3-YL)ACETYL)PIPERIDIN-4-YL)ACETIC ACID
Systematic Name English
lapaquistat [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29703
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C96287
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
EPA CompTox
DTXSID80172294
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
INN
8662
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
FDA UNII
PEZ79BV72X
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
SMS_ID
300000036999
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
WIKIPEDIA
LAPAQUISTAT
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
PUBCHEM
9960389
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
CAS
189059-71-0
Created by admin on Mon Mar 31 19:40:50 GMT 2025 , Edited by admin on Mon Mar 31 19:40:50 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
In differentiated RD cells inhibition of cholesterol synthesis.
IC50
Related Record Type Details
PARENT -> METABOLITE ACTIVE
In RD cells inhibited cholesterol biosynthesis
IC50
Related Record Type Details
ACTIVE MOIETY
Effective at lowering low-density lipoprotein cholesterol in a dose-dependent manner, development of the drug was ceased due to observations in clinical trials that it might cause liver damage